<DOC>
	<DOCNO>NCT01914913</DOCNO>
	<brief_summary>Retinitis pigmentosa eye disease damage retina . The retina layer tissue back inner eye convert light image nerve signal send brain.Autologous Bone Marrow derive Mono Nuclear Stem Cell ( BMMNCs ) use condition .</brief_summary>
	<brief_title>Clinical Study Evaluate Safety Efficacy BMMNC Retinitis Pigmentosa</brief_title>
	<detailed_description>This study involve 8 visit 1Â½ year .Each participant enrol study per inclusion exclusion criterion .Informed consent take subject include study . Subject underwent specific test participant 's vision health . These visit may include visual exam , blood draw laboratory testing , brief medical history exam , occasionally questionnaire ( survey ) , addition visit surgical procedure . The primary outcome study visual acuity score one year stem cell therapy . Follow-up visit require regularly determine effectiveness Autologous Bone Marrow derive Mono Nuclear Stem Cell ( BMMNCs ) RP .</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<criteria>Age 1865 Diagnosis retinitis pigmentosa willingness undergo Bone marrow umbilical cord derive Mesenchymal stem cell transplantation . To give informed consent well sign require Informed Consent Form ( ICF ) study . willingness regularly visit hospital / clinic follow follow period / prior agree time point per protocol . Positive test result HIV AIDS complex , HCV ( hepatitis C virus ) , HbsAg Syphilis Women pregnant lactating Complications diabetic retinopathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>retinitis pigmentosa</keyword>
	<keyword>Bone marrow</keyword>
	<keyword>stem cell</keyword>
	<keyword>BMMNC</keyword>
</DOC>